Investigational Site Number 380003

Varese 21100

0 studies enrolling now · 2 studies all time

What they study most

Hematopoietic Neoplasm

Studies at this site

• Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib — Stopped early
• Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis — Completed